Sinofn Health
In the rapidly evolving landscape of functional foods, SINOFN Health stands at the intersection of biotechnology and consumer wellness. Our Collagen Glow Berries series is not merely a product; it is the culmination of years of molecular research conducted in partnership with the Chinese Academy of Sciences (CAS). By utilizing advanced enzymatic hydrolysis, we achieve a collagen peptide structure with optimal bioavailability, ensuring systemic absorption that translates into visible skin health and metabolic vitality.
Our roadmap prioritizes "Precision Nutrition." As we look toward 2030, SINOFN is scaling deep learning algorithms for personalized formulation development. We are moving beyond general wellness, integrating specific biomarker tracking into our supplement design processes. Our factory lines are currently being upgraded for automated 'smart manufacturing,' which allows for smaller, agile batch runs without sacrificing cost-efficiency, meeting the needs of D2C brands worldwide.
Leveraging China's robust industrial infrastructure, SINOFN provides a supply chain buffer that multinational brands rely on. Our vertically integrated system—from raw material sourcing (non-GMO, sustainably harvested) to advanced GMP-certified processing—mitigates logistics volatility. We operate with a transparency-first model, providing clients with blockchain-enabled traceability for every batch.
Navigating global regulations (FDA, EFSA, TGA) is complex. SINOFN provides specialized consulting for international clients, ensuring that our collagen formulations align with target market requirements. Whether it's allergen labeling, potency verification, or health claim substantiation, our regulatory affairs team bridges the gap between Asian manufacturing precision and Western market compliance.
Driven by clinical necessity. Mrs. Liu’s background in medical dietetics for PKU patients ensures that every product manufactured by SINOFN is designed with human efficacy as the primary metric, not just market trends. This 'Patient-First' philosophy is embedded in our corporate DNA, distinguishing us from profit-only contract manufacturers.
A: We use proprietary enzymatic hydrolysis processes that break down collagen molecules into low-Dalton peptides, ensuring rapid intestinal absorption and better skin barrier integration.
A: Yes. Our pilot-scale prototyping lines allow for low-MOQ (Minimum Order Quantity) runs, enabling startups to test market viability before full-scale commercialization.
A: We are certified with ISO9001, ISO22000, HACCP, and HALAL, ensuring our products meet rigorous safety and ethical standards for export to over 50 countries.